Division of Palliative Care Medicine, Department of Oncology, University of Alberta, Edmonton, Alberta, Canada.
J Pain Symptom Manage. 2011 Feb;41(2):456-68. doi: 10.1016/j.jpainsymman.2010.04.020. Epub 2010 Sep 15.
The Edmonton Symptom Assessment System (ESAS) is a widely used, self-report symptom intensity tool for assessing nine common symptoms in palliative care, with ratings ranging from 0 (none, best) to 10 (worst). Based on a "think-aloud" study of 20 advanced cancer patients, the ESAS was revised (ESAS-r).
To compare the consistency of patients' symptom ratings and obtain patient perspectives regarding ease of understanding and completion between the ESAS and ESAS-r.
Cognitively intact patients (n=160) were recruited from eight palliative care sites in Canada and Switzerland, using cross-sectional sampling (20 per site). Consenting patients completed the ESAS, ESAS-r, and a structured interview. Intraclass correlation coefficients (ICCs) were calculated to assess rating consistency.
In total, 1046 patients were screened. One hundred sixty were enrolled and evaluable (female 51%, median age 61 [range 34-92], lung cancer 26%, gastrointestinal cancer 22%). Mean ESAS scores ranged from 1.2 (nausea, standard deviation [SD] 2.1) to 4.3 (appetite, SD 3.3). ICCs ranged from 0.65 to 0.83, with lowest scores (<0.8) for drowsiness, appetite, and well-being. Although most patients rated both versions as very easy or easy to understand and complete, the ESAS-r was significantly easier to understand than the ESAS (P=0.008). Significantly, more patients preferred the ESAS-r (39%) than the ESAS (14%, P<0.001) because of its definitions, clarity, and format.
The ESAS-r retains core elements of the ESAS, with improved interpretation and clarity of symptom intensity assessment. It represents the next generation of ESAS development, with further validation recommended for drowsiness, appetite, and well-being.
埃德蒙顿症状评估系统(ESAS)是一种广泛使用的自评症状强度工具,用于评估姑息治疗中常见的九种症状,评分范围从 0(无,最佳)到 10(最差)。基于对 20 名晚期癌症患者的“出声思考”研究,ESAS 进行了修订(ESAS-r)。
比较患者症状评分的一致性,并获得患者对 ESAS 和 ESAS-r 的理解和完成难易程度的看法。
使用横断面抽样(每个地点 20 例),从加拿大和瑞士的 8 个姑息治疗地点招募认知功能正常的患者(n=160)。同意参与的患者完成 ESAS、ESAS-r 和结构化访谈。计算组内相关系数(ICC)以评估评分一致性。
共有 1046 名患者接受了筛查。纳入并可评估的患者有 160 名(女性 51%,中位年龄 61 [范围 34-92],肺癌 26%,胃肠道癌 22%)。ESAS 的平均评分范围从 1.2(恶心,标准差[SD] 2.1)到 4.3(食欲,SD 3.3)。ICC 范围从 0.65 到 0.83,最低评分(<0.8)为嗜睡、食欲和幸福感。尽管大多数患者认为两个版本都非常容易理解和完成,但 ESAS-r 比 ESAS 更容易理解(P=0.008)。重要的是,更多的患者更喜欢 ESAS-r(39%)而不是 ESAS(14%,P<0.001),因为它的定义、清晰度和格式。
ESAS-r 保留了 ESAS 的核心要素,提高了对症状强度评估的解释和清晰度。它代表了 ESAS 发展的下一代,建议进一步验证嗜睡、食欲和幸福感。